Literature DB >> 22664034

Complication arising from a duplicated inferior vena cava following laparoscopic living donor nephrectomy: a case report.

P G Christakis1, B Cimsit, S Kulkarni.   

Abstract

Selecting a kidney for living donor nephrectomy is driven by the tenet that donors are left with the higher functioning kidney. Traditionally, the left kidney is used because it has a longer renal vein, which aids anastamosis, and has an easier surgical approach. Anomalous left renal vasculature is not considered a contraindication to living donor nephrectomy. In the case of duplicated inferior vena cava, no specific considerations have been reported. We present a 42-year-old patient with infrarenal duplication of the vena cava who underwent laparoscopic living donor nephrectomy. His postoperative course was complicated by painful scrotal swelling necessitating multiple emergency room visits. Ultrasonography revealed bilateral hydroceles 5 weeks after surgery, which resolved with the use of a scrotal sling. Intraoperative ligation of a visibly dilated left gonadal vein was the likely etiology. Careful consideration should be taken in living donor nephrectomy in patients with duplication of inferior vena cava.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22664034     DOI: 10.1016/j.transproceed.2011.11.064

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  3 in total

1.  Inferior vena cava duplication.

Authors:  Massimo Chiarugi; Lorenzo Fregoli; Pietro Iacconi
Journal:  Updates Surg       Date:  2015-05-29

2.  Pure retroperitoneoscopic donor nephrectomy in duplication of inferior vena cava: A series of four cases.

Authors:  Bipin Chandra Pal; Pranjal R Modi; Syed Jamal Rizvi; Rohit Chauhan; Suresh Kumar; Shruti P Gandhi; Vivek B Kute; Hargovind L Trivedi
Journal:  Urol Ann       Date:  2017 Oct-Dec

3.  Wilms tumor with inferior vena cava duplication: a rare case report.

Authors:  Feng Guo; Tianyou Li; Wei Liu; Gang Wang; Rui Ma; Rongde Wu
Journal:  BMC Urol       Date:  2018-10-19       Impact factor: 2.264

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.